Search by Drug Name or NDC

    NDC 50991-0788-02 Alahist PE 2; 7.5 mg/1; mg/1 Details

    Alahist PE 2; 7.5 mg/1; mg/1

    Alahist PE is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Poly Pharmaceuticals, Inc.. The primary component is DEXBROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 50991-0788
    Product ID 50991-788_f4bf7f15-6579-71c4-e053-2a95a90aeb27
    Associated GPIs 43993002500318
    GCN Sequence Number 081496
    GCN Sequence Number Description dexbrompheniramin/phenylephrin TABLET 2MG-7.5 MG ORAL
    HIC3 Z2N
    HIC3 Description 1ST GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION
    GCN 48628
    HICL Sequence Number 036892
    HICL Sequence Number Description DEXBROMPHENIRAMINE MALEATE/PHENYLEPHRINE HCL
    Brand/Generic Brand
    Proprietary Name Alahist PE
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dexbrompheniramine Maleate, Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2; 7.5
    Active Ingredient Units mg/1; mg/1
    Substance Name DEXBROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Poly Pharmaceuticals, Inc.
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 50991-0788-02 (50991078802)

    NDC Package Code 50991-788-02
    Billing NDC 50991078802
    Package 12 TABLET in 1 BLISTER PACK (50991-788-02)
    Marketing Start Date 2020-08-24
    NDC Exclude Flag N
    Pricing Information N/A